Literature DB >> 15031164

Oligocone trichromacy: a rare and unusual cone dysfunction syndrome.

M Michaelides1, G E Holder, K Bradshaw, D M Hunt, J D Mollon, A T Moore.   

Abstract

AIM: To describe the phenotype of a case series of six patients with oligocone trichromacy.
METHODS: The six affected individuals underwent an ophthalmological examination, electrophysiological testing and detailed psychophysical assessment.
RESULTS: All six affected patients had a history of moderately reduced visual acuity (6/12 to 6/24) from infancy, not improved by full spectacle correction. They complained of mild photophobia and they were not aware of any colour vision deficiency. They had no nystagmus and fundi were normal. Electrophysiological testing revealed either absent/profoundly reduced cone flicker responses or preserved but delayed and mildly reduced flicker responses. Colour vision was found to be within normal limits, but some patients showed mildly elevated discrimination thresholds along all axes.
CONCLUSION: The largest case series to date of patients with oligocone trichromacy is presented. The electrophysiological findings suggest that there may be more than one disease mechanism. The mode of inheritance is likely to be autosomal recessive, and while previous reports have suggested that this disorder is stationary, in one of these families there is clinical evidence of progression.

Entities:  

Mesh:

Year:  2004        PMID: 15031164      PMCID: PMC1772119          DOI: 10.1136/bjo.2003.028142

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  15 in total

1.  Standard for pattern electroretinography. International Society for Clinical Electrophysiology of Vision.

Authors:  M Bach; M Hawlina; G E Holder; M F Marmor; T Meigen; Y Miyake
Journal:  Doc Ophthalmol       Date:  2000-07       Impact factor: 2.379

2.  CONE DYSFUNCTION SYNDROMES.

Authors:  G GOODMAN; H RIPPS; I M SIEGEL
Journal:  Arch Ophthalmol       Date:  1963-08

3.  Standard for clinical electro-oculography. International Society for Clinical Electrophysiology of Vision.

Authors:  M F Marmor; E Zrenner
Journal:  Arch Ophthalmol       Date:  1993-05

4.  Mutations in the CNGB3 gene encoding the beta-subunit of the cone photoreceptor cGMP-gated channel are responsible for achromatopsia (ACHM3) linked to chromosome 8q21.

Authors:  S Kohl; B Baumann; M Broghammer; H Jägle; P Sieving; U Kellner; R Spegal; M Anastasi; E Zrenner; L T Sharpe; B Wissinger
Journal:  Hum Mol Genet       Date:  2000-09-01       Impact factor: 6.150

Review 5.  Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis.

Authors:  G E Holder
Journal:  Prog Retin Eye Res       Date:  2001-07       Impact factor: 21.198

Review 6.  Assessing retinal function with the multifocal technique.

Authors:  D C Hood
Journal:  Prog Retin Eye Res       Date:  2000-09       Impact factor: 21.198

7.  Differential diagnosis of typical and atypical congenital achromatopsia. Analysis of a progressive foveal dystrophy and a nonprogressive oligo-cone trichromasy (general cone dysfunction without achromatopsia), both of which at first had been diagnosed as achromatopsia.

Authors:  T Neuhann; H Krastel; W Jaeger
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-12-08

8.  Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the alpha subunit of cone transducin (GNAT2).

Authors:  I A Aligianis; T Forshew; S Johnson; M Michaelides; C A Johnson; R C Trembath; D M Hunt; A T Moore; E R Maher
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

9.  Mutations in the cone photoreceptor G-protein alpha-subunit gene GNAT2 in patients with achromatopsia.

Authors:  Susanne Kohl; Britta Baumann; Thomas Rosenberg; Ulrich Kellner; Birgit Lorenz; Maria Vadalà; Samuel G Jacobson; Bernd Wissinger
Journal:  Am J Hum Genet       Date:  2002-06-20       Impact factor: 11.025

View more
  9 in total

Review 1.  [Achromatopsia].

Authors:  C M Poloschek; S Kohl
Journal:  Ophthalmologe       Date:  2010-06       Impact factor: 1.059

2.  Long-term follow-up of two patients with oligocone trichromacy.

Authors:  Vasily Smirnov; Isabelle Drumare; Ikram Bouacha; Bernard Puech; Sabine Defoort-Dhellemmes
Journal:  Doc Ophthalmol       Date:  2015-07-03       Impact factor: 2.379

3.  Integrity of the cone photoreceptor mosaic in oligocone trichromacy.

Authors:  Michel Michaelides; Jungtae Rha; Elise W Dees; Rigmor C Baraas; Melissa L Wagner-Schuman; John D Mollon; Adam M Dubis; Mette K G Andersen; Thomas Rosenberg; Michael Larsen; Anthony T Moore; Joseph Carroll
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

Review 4.  The cone dysfunction syndromes.

Authors:  M Michaelides; D M Hunt; A T Moore
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

Review 5.  [Clinical findings and diagnostics of cone dystrophy].

Authors:  U Kellner; S Kellner
Journal:  Ophthalmologe       Date:  2009-02       Impact factor: 1.059

Review 6.  The cone dysfunction syndromes.

Authors:  Jonathan Aboshiha; Adam M Dubis; Joseph Carroll; Alison J Hardcastle; Michel Michaelides
Journal:  Br J Ophthalmol       Date:  2015-03-13       Impact factor: 4.638

7.  A Rare Form of Retinal Dystrophy Caused by Hypomorphic Nonsense Mutations in CEP290.

Authors:  Susanne Roosing; Frans P M Cremers; Frans C C Riemslag; Marijke N Zonneveld-Vrieling; Herman E Talsma; Francoise J M Klessens-Godfroy; Anneke I den Hollander; L Ingeborgh van den Born
Journal:  Genes (Basel)       Date:  2017-08-22       Impact factor: 4.096

8.  Gene Expression Profiling of the Optic Nerve Head of Patients with Primary Open-Angle Glaucoma.

Authors:  Xinrong Wang; Ke Gong; Haiyan Li; Congyi Wang; Chaoyi Qu; Hui Li
Journal:  J Ophthalmol       Date:  2017-04-05       Impact factor: 1.909

9.  Retinal Architecture in ​RGS9- and ​R9AP-Associated Retinal Dysfunction (Bradyopsia).

Authors:  Rupert W Strauss; Adam M Dubis; Robert F Cooper; Rola Ba-Abbad; Anthony T Moore; Andrew R Webster; Alfredo Dubra; Joseph Carroll; Michel Michaelides
Journal:  Am J Ophthalmol       Date:  2015-09-03       Impact factor: 5.258

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.